ArticleInternational journal of clinical oncology2025

Elevated proportion of eosinophils predicts immune-related adverse events and improved survival in patients with gastric cancer treated with nivolumab.

Sohei Matsumoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.